tiprankstipranks
XBiotech (XBIT)
NASDAQ:XBIT

XBiotech Stock Price & Analysis

282 Followers

XBIT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.70 - $16.47
Previous Close$3.7
Volume43.79K
Average Volume (3M)55.51K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$225.79M
Total Debt (Recent Filing)$0.00
P/E Ratio-4.2
Beta0.39
Next EarningsMay 09, 2019
EPS EstimateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-0.88
Shares Outstanding30,439,275
R-Squared0.12
Standard Deviation0.19
10 Day Avg. Volume40,805
30 Day Avg. Volume55,509
P/B Ratio0.44
P/S Ratio10.19
P/CF Ratio2.50
P/FCF Ratio-1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha0.00326
Number of Analyst Covering0


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

XBIT FAQ

What was XBiotech’s price range in the past 12 months?
XBiotech lowest stock price was $3.70 and its highest was $16.47 in the past 12 months.
    What is XBiotech’s market cap?
    Currently, no data Available
    When is XBiotech’s upcoming earnings report date?
    XBiotech’s upcoming earnings report date is May 09, 2019 which is 1238 days ago.
      How were XBiotech’s earnings last quarter?
      XBiotech released its earnings results on Mar 14, 2019. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.17.
        Is XBiotech overvalued?
        According to Wall Street analysts XBiotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does XBiotech pay dividends?
          XBiotech pays a Notavailable dividend of $2.5 which represents an annual dividend yield of N/A. XBiotech’s last Notavailable dividend payment was on Jul 23, 2021. XBiotech’s upcoming ex-dividend date is Jul 15, 2021
            What is XBiotech’s EPS estimate?
            XBiotech’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does XBiotech have?
            XBiotech has 30,439,276 shares outstanding.
              What happened to XBiotech’s price movement after its last earnings report?
              XBiotech reported an EPS of -$0.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
                Which hedge fund is a major shareholder of XBiotech?
                Among the largest hedge funds holding XBiotech’s share is Caxton Associates LP. It holds XBiotech’s shares valued at N/A.

                  ---

                  XBiotech Stock Analysis

                  Smart ScoreNeutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  4
                  The XBiotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  XBiotech

                  XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  AbbVie
                  Amgen
                  Gilead Sciences
                  Moderna
                  Vertex Pharmaceuticals

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis